Chemomab Therapeutics Ltd DRC
$ 1.65
-7.30%
12 Jun - close price
- Market Cap 11,880,600 USD
- Current Price $ 1.65
- High / Low $ 1.85 / 1.65
- Stock P/E N/A
- Book Value 1.49
- EPS -1.12
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.40 %
- ROE -0.71 %
- 52 Week High 5.04
- 52 Week Low 1.35
About
Chemomab Therapeutics Ltd. is dedicated to the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases. The company is headquartered in Tel Aviv, Israel.
Analyst Target Price
$15.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-14 | 2026-03-19 | 2025-11-13 | 2025-08-14 | 2025-05-15 | 2025-03-03 | 2024-11-14 | 2024-08-21 | 2024-05-09 | 2024-03-07 | 2023-11-09 | 2023-08-14 |
| Reported EPS | -0.003 | -0.003 | -0.004 | -0.016 | -0.007 | -0.008 | -0.01 | -0.26 | -0.2753 | -0.2654 | -0.02 | -0.036 |
| Estimated EPS | 0 | -0.01 | -0.005 | -0.1 | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | -0.02 | -0.02 | -0.03 |
| Surprise | -0.003 | 0.007 | 0.001 | 0.084 | 0.003 | 0.002 | 0 | -0.25 | -0.2453 | -0.2454 | 0 | -0.006 |
| Surprise Percentage | None% | 70% | 20% | 84% | 30% | 20% | 0% | -2500% | -817.6667% | -1227% | 0% | -20% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
